Focus areas
Exploring partnerships across healthcare.
Our core focus is commercially viable healthcare products and differentiated technologies. In the areas below, we look at the evidence, market demand and partnership readiness of each asset, and we also welcome new proposals in related fields.
Pharmaceuticals
We explore opportunities for prescription and OTC medicines, a range of dosage forms and drug-delivery technologies, both for introduction into Korea and for partnerships with companies abroad.
We look at the value of each product and technology, its stage of development and commercialisation, and the market environment, to find the right business direction.
APIs
We explore supply partnerships for active pharmaceutical ingredients and intermediates with Korean manufacturers.
We review manufacturing quality, documentation and supply readiness to find the right fit on both sides.
Medical Devices
We look at devices and related solutions used across diagnosis, treatment and care, including wound care and procedure consumables.
We discuss partners and routes to market that meet the needs of clinical practice.
Medical Aesthetics
We review the business potential of medical aesthetic products and procedure-related technologies and solutions.
Looking at the evidence and characteristics of each product, clinical demand and market trends, we explore routes to introduction, supply and partnership with specialist channels.
Functional Nutrition & Specialty Ingredients
We explore partnerships for functional nutrition products, specialty ingredients, health-related raw materials and nutrition solutions.
Considering the characteristics of ingredients and finished products, target customers and market demand, we discuss introduction, supply and business-to-business partnerships.
Supportive Oncology Care
We look at products and solutions that support the daily care and quality of life of people with cancer.
Focusing on skin and oral care and nutritional support, we review partnership opportunities that meet the needs of patients and clinical teams.